全文获取类型
收费全文 | 23740篇 |
免费 | 1754篇 |
国内免费 | 48篇 |
专业分类
耳鼻咽喉 | 221篇 |
儿科学 | 768篇 |
妇产科学 | 667篇 |
基础医学 | 3029篇 |
口腔科学 | 286篇 |
临床医学 | 3477篇 |
内科学 | 4375篇 |
皮肤病学 | 358篇 |
神经病学 | 2283篇 |
特种医学 | 464篇 |
外科学 | 2551篇 |
综合类 | 214篇 |
一般理论 | 49篇 |
预防医学 | 3014篇 |
眼科学 | 306篇 |
药学 | 1601篇 |
1篇 | |
中国医学 | 29篇 |
肿瘤学 | 1849篇 |
出版年
2024年 | 30篇 |
2023年 | 275篇 |
2022年 | 396篇 |
2021年 | 860篇 |
2020年 | 550篇 |
2019年 | 866篇 |
2018年 | 933篇 |
2017年 | 706篇 |
2016年 | 691篇 |
2015年 | 808篇 |
2014年 | 1057篇 |
2013年 | 1436篇 |
2012年 | 2089篇 |
2011年 | 2072篇 |
2010年 | 1122篇 |
2009年 | 918篇 |
2008年 | 1599篇 |
2007年 | 1631篇 |
2006年 | 1433篇 |
2005年 | 1433篇 |
2004年 | 1252篇 |
2003年 | 1105篇 |
2002年 | 987篇 |
2001年 | 141篇 |
2000年 | 81篇 |
1999年 | 110篇 |
1998年 | 183篇 |
1997年 | 156篇 |
1996年 | 120篇 |
1995年 | 78篇 |
1994年 | 60篇 |
1993年 | 65篇 |
1992年 | 37篇 |
1991年 | 41篇 |
1990年 | 28篇 |
1989年 | 23篇 |
1988年 | 17篇 |
1987年 | 21篇 |
1986年 | 29篇 |
1985年 | 17篇 |
1984年 | 20篇 |
1983年 | 12篇 |
1982年 | 13篇 |
1981年 | 11篇 |
1980年 | 5篇 |
1979年 | 5篇 |
1978年 | 4篇 |
1977年 | 6篇 |
1972年 | 3篇 |
1971年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 35 毫秒
991.
This systematic literature review examined whole food or whole diet interventions to treat depression. The inclusion criteria encompassed adults, depression, a recognized depression scale and a whole food or diet intervention. APA PsychINFO, CINAHL, the Cochrance Central Register of Controlled Trails, MEDLINE and Scopus were searched for original research addressing diet as a treatment for depression in adult populations. The quality of the study was assessed using the Academy of Nutrition and Dietetics Quality Criteria Checklist. Seven studies; with 49,156 participants; met the eligibility criteria. All these studies found positive outcomes with depression levels decreasing after dietary intervention. The calculated effect size varied from small (Cohen’s d = 0.32) to very large (Cohen’s d = 1.82). The inconsistent nature of the studies limited the synthesis of the data. Recommendations are provided to enhance future study design and measurement outcomes. Overall, the findings show a positive result for diets that promote an increased intake of fresh produce, wholegrains, low-fat dairy and lean protein sources, while also decreasing the intake of processed and high-fat foods. No funding was provided for this review. The protocol for this review is registered with PROSPERO (CRD42020210426). 相似文献
992.
Michelle Harvie Mary Pegington Sacha J. Howell Nigel Bundred Phil Foden Judith Adams Lee Graves Alastair Greystoke Mark P. Mattson Roy G. Cutler Julie Williamson Karen Livingstone Debbie McMullen Katharine Sellers Cheryl Lombardelli Grace Cooper Sarah McDiarmid Anthony Howell 《British journal of cancer》2022,126(8):1157
Background Excess adiposity at diagnosis and weight gain during chemotherapy is associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of intermittent energy restriction (IER) vs continuous energy restriction (CER) for weight control and toxicity reduction during chemotherapy.Methods One hundred and seventy-two women were randomised to follow IER or CER throughout adjuvant/neoadjuvant chemotherapy. Primary endpoints were weight and body fat change. Secondary endpoints included chemotherapy toxicity, cardiovascular risk markers, and correlative markers of metabolism, inflammation and oxidative stress.Results Primary analyses showed non-significant reductions in weight (−1.1 (−2.4 to +0.2) kg, p = 0.11) and body fat (−1.0 (−2.1 to +0.1) kg, p = 0.086) in IER compared with CER. Predefined secondary analyses adjusted for body water showed significantly greater reductions in weight (−1.4 (−2.5 to −0.2) kg, p = 0.024) and body fat (−1.1 (−2.1 to −0.2) kg, p = 0.046) in IER compared with CER. Incidence of grade 3/4 toxicities were comparable overall (IER 31.0 vs CER 36.5%, p = 0.45) with a trend to fewer grade 3/4 toxicities with IER (18%) vs CER (31%) during cycles 4–6 of primarily taxane therapy (p = 0.063).Conclusions IER is feasible during chemotherapy. The potential efficacy for weight control and reducing toxicity needs to be tested in future larger trials.Clinical trial registration ISRCTN04156504.Subject terms: Randomized controlled trials, Breast cancer, Nutrition, Weight management, Breast cancer 相似文献
993.
994.
Michelle J Hunt Elizabeth LC Salisbury Dorothy M Painter Stephen Lee 《The Australasian journal of dermatology》1996,37(4):196-198
A 56-year-old male presented with a pruritic, generalized vesiculobullous eruption. His past history revealed classical symptoms of limited Hailey-Hailey disease for 34 years. Clinically, vesicles, bullae and occasional pustules were present and multiple biopsies confirmed this to be an unusual presentation of Hailey-Hailey disease. Various therapeutic modalities including topical and oral antibiotics, oral prednisone and dapsone failed to achieve sustained remission. Treatment with lowdose oral etretinate (25 mg daily) produced marked clinical improvement with complete suppression of new vesicle formation after 6 weeks. 相似文献
995.
Functional connectivity among brain regions has been investigated via an analysis of correlations between regional signal fluctuations recorded in magnetic resonance (MR) images obtained in a steady state. In comparison with studies of functional connectivity that utilize task manipulations, the analysis of correlations in steady state data is less susceptible to confounds arising when functionally unrelated brain regions respond in similar ways to changes in task. A new approach to identifying interregional correlations in steady state data makes use of two independent data sets. Regions of interest (ROIs) are defined and hypotheses regarding their connectivity are generated in one data set. The connectivity hypotheses are then evaluated in the remaining (independent) data set by analyzing low frequency temporal correlations between regions. The roles of the two data sets are then reversed and the process repeated, perhaps multiple times. This method was illustrated by application to the language system. The existence of a functional connection between Broca's area and Wernicke's area was confirmed in healthy subjects at rest. An increase in this functional connection when the language system was actively engaged (when subjects were continuously listening to narrative text) was also confirmed. In a second iteration of analyses, a correlation between Broca's area and a region in left premotor cortex was found to be significant at rest and to increase during continuous listening. These findings suggest that the proposed methodology can reveal the presence and strength of functional connections in high-level cognitive systems. 相似文献
996.
Richard S. E. Keefe Robert W. Buchanan Stephen R. Marder Nina R. Schooler Ashish Dugar Milana Zivkov Michelle Stewart 《Schizophrenia bulletin》2013,39(2):417-435
In light of the number of studies conducted to examine the treatment of cognitive impairment associated with schizophrenia (CIAS), we critically reviewed recent CIAS trials. Trials were identified through searches of the website “www.clinicaltrials.gov” using the terms “schizophrenia AND cognition,” “schizophrenia AND neurocognition,” “schizophrenia AND neurocognitive tests,” “schizophrenia AND MATRICS,” “schizophrenia AND MCCB,” “schizophrenia AND BACS,” “schizophrenia AND COGSTATE,” and “schizophrenia AND CANTAB” and “first-episode schizophrenia AND cognition.” The cutoff date was 20 April 2011. Included trials were conducted in people with schizophrenia, the effects on cognition were either a primary or secondary outcome, and the effect of a pharmacologically active substance was examined. Drug challenge, pharmacokinetic, pharmacodynamic, or prodrome of psychosis studies were excluded. We identified 118 trials, with 62% using an add-on parallel group design. The large majority of completed trials were underpowered to detect moderate effect sizes, had ≤8 weeks duration, and were performed in samples of participants with chronic stable schizophrenia. The ongoing add-on trials are longer, have larger sample sizes (with a number of them being adequately powered to detect moderate effect sizes), and are more likely to use a widely accepted standardized cognitive battery (eg, the MATRICS Consensus Cognitive Battery) and MATRICS guidelines. Ongoing studies performed in subjects with recent onset schizophrenia may help elucidate which subjects are most likely to show an effect in cognition. New insights into the demands of CIAS trial design and methodology may help increase the probability of identifying treatments with beneficial effect on cognitive impairment in schizophrenia. 相似文献
997.
998.
Recurrence of Plasmodium falciparum after treatment with quinine and doxycycline in the Amazon basin
下载免费PDF全文
![点击此处可从《Tropical medicine & international health : TM & IH》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Margarete do Socorro Mendonça Gomes José Luiz Fernandes Vieira Álvaro Augusto Ribeiro D'Almeida Couto Vanja Suely Calvosa D'Almeida Couto Michelle Valéria Dias Ferreira Vieira Francis Christian da Silva Pereira Ricado Luiz Dantas Machado 《Tropical medicine & international health : TM & IH》2017,22(2):133-138
999.
Samantha G. Bromfield MS C. Barrett Bowling MD MSPH Rikki M. Tanner MPH Carmen A. Peralta MD Michelle C. Odden PhD Suzanne Oparil MD Paul Muntner PhD 《Journal of clinical hypertension (Greenwich, Conn.)》2014,16(4):270-276
The authors examined trends in systolic blood pressure (SBP) and diastolic blood pressure (DBP) and the prevalence, awareness, treatment, and control of hypertension in 1988–1994 (n=1164), 1999–2004 (n=1,026), and 2005–2010 (n=1048) among US adults 80 years and older in serial National Health and Nutrition Examination Surveys. Hypertension was defined as SBP ≥140 mm Hg, DBP ≥90 mm Hg, or use of antihypertensive medication. Awareness and treatment were defined by self‐report and control as SBP/DBP<140/90 mm Hg. Mean SBP decreased from 147.3 mm Hg to 140.1 mm Hg and mean DBP from 70.2 mm Hg to 59.4 mm Hg between 1988–1994 and 2005–2010. The prevalence, awareness, and treatment of hypertension each increased over time. Controlled hypertension increased from 30.4% in 1988–1994 to 53.1% in 2005–2010. The proportion of patients taking 3 classes of antihypertensive medication increased from 7.0% to 30.9% between 1988–1994 and 2005–2010. Increases in awareness, treatment, and control of hypertension and antihypertensive polypharmacy have been observed among very old US adults.The US population is aging and it is projected that the number of US adults 80 years and older will triple by 2050.1 Hypertension is one of the most important risk factors for coronary heart disease, stroke, and heart failure, each of which has a high incidence in the very old patients.2, 3, 4 A meta‐analysis of randomized trials that included participants 80 years and older found antihypertensive treatment to be associated with a reduced risk for stroke, cardiovascular events, and heart failure.5 Multi‐morbidity and functional impairment are common among the very old and the applicability of antihypertensive treatment trial results to this population has been questioned.6, 7, 8, 9 A major concern in using antihypertensive medications in the very old is the potential increased risk for adverse events including falls and myocardial infarction associated with low blood pressure (BP).10, 11, 12 Providers must often weigh potential cardiovascular benefits against the perceived risks of pharmacologic BP‐lowering among the very old. For these reasons, treatment patterns may be different for the very old vs the general US population.Given the anticipated growth of the very old population in the United States, there is a need to document the prevalence of hypertension and BP treatment patterns in this population. Such information could be used to guide the development and implementation of approaches for improving BP management in this group. Therefore, we examined secular changes in SBP and DBP and hypertension prevalence, awareness, treatment, and control from 1988–1994 through 2005–2010 among representative samples of US adults aged 80 and older. In addition, we examined trends in the use of different classes of antihypertensive medications and the prevalence of antihypertensive polypharmacy among very old US adults. 相似文献
1000.
Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia
下载免费PDF全文
![点击此处可从《British journal of haematology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Rosemary Sutton Peter J. Shaw Nicola C. Venn Tamara Law Anuruddhika Dissanayake Tatjana Kilo Michelle Haber Murray D. Norris Chris Fraser Frank Alvaro Tamas Revesz Toby N. Trahair Luciano Dalla‐Pozza Glenn M. Marshall Tracey A. O'Brien 《British journal of haematology》2015,168(3):395-404
Minimal residual disease (MRD) during early chemotherapy is a powerful predictor of relapse in acute lymphoblastic leukaemia (ALL) and is used in children to determine eligibility for allogeneic haematopoietic stem cell transplantation (HSCT) in first (CR1) or later complete remission (CR2/CR3). Variables affecting HSCT outcome were analysed in 81 children from the ANZCHOG ALL8 trial. The major cause of treatment failure was relapse, with a cumulative incidence of relapse at 5 years (CIR) of 32% and treatment‐related mortality of 8%. Leukaemia‐free survival (LFS) and overall survival (OS) were similar for HSCT in CR1 (LFS 62%, OS 83%, n = 41) or CR2/CR3 (LFS 60%, OS 72%, n = 40). Patients achieving bone marrow MRD negativity pre‐HSCT had better outcomes (LFS 83%, OS 92%) than those with persistent MRD pre‐HSCT (LFS 41%, OS 64%, P < 0·0001) or post‐HSCT (LFS 35%, OS 55%, P < 0·0001). Patients with B‐other ALL had more relapses (CIR 50%, LFS 41%) than T‐ALL and the main precursor‐B subtypes including BCR‐ABL1, KMT2A (MLL), ETV6‐RUNX1 (TEL‐AML1) and hyperdiploidy >50. A Cox multivariate regression model for LFS retained both B‐other ALL subtype (hazard ratio 4·1, P = 0·0062) and MRD persistence post‐HSCT (hazard ratio 3·9, P = 0·0070) as independent adverse prognostic variables. Persistent MRD could be used to direct post‐HSCT therapy. 相似文献